SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases
Authors
Keywords
-
Journal
Clinical and Translational Medicine
Volume 11, Issue 11, Pages -
Publisher
Wiley
Online
2021-11-04
DOI
10.1002/ctm2.591
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway
- (2019) Ming-Hui Zhang et al. ONCOGENE
- The deubiquitinating enzyme USP48 stabilizes TRAF2 and reduces E-cadherin-mediated adherens junctions
- (2018) Shuang Li et al. FASEB JOURNAL
- PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response
- (2018) Dongha Kim et al. MOLECULAR CELL
- Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
- (2017) Linda Xiaoyan Li et al. JOURNAL OF CLINICAL INVESTIGATION
- The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor α (TNF-α) Production
- (2015) Guiliang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis
- (2014) Amna Sajjad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Histone Methyltransferase Ash1l Suppresses Interleukin-6 Production and Inflammatory Autoimmune Diseases by Inducing the Ubiquitin-Editing Enzyme A20
- (2013) Meng Xia et al. IMMUNITY
- Regulation of estrogen receptor by histone methyltransferase SMYD2-mediated protein methylation
- (2013) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function
- (2012) Tobias Voelkel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response
- (2011) S. Gardam et al. BLOOD
- Non-canonical NF-κB signaling activation and regulation: principles and perspectives
- (2011) Bahram Razani et al. IMMUNOLOGICAL REVIEWS
- TNF -induced noncanonical NF- B activation is attenuated by RIP1 through stabilization of TRAF2
- (2011) J.-Y. Kim et al. JOURNAL OF CELL SCIENCE
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Inhibition of NF- B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
- (2010) N. Shembade et al. SCIENCE
- CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
- (2009) S-C Sun CELL DEATH AND DIFFERENTIATION
- TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis
- (2009) James E. Vince et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PKC Phosphorylation of TRAF2 Mediates IKKα/β Recruitment and K63-Linked Polyubiquitination
- (2009) Shitao Li et al. MOLECULAR CELL
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
- Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
- (2008) Sivakumar Vallabhapurapu et al. NATURE IMMUNOLOGY
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
- (2008) Brian J Zarnegar et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started